With a trend opposite to IDO1, many of the neoplasms presented a low expression of PD-L1 (139; 77%, Figure 2b), both regarding adenocarcinomas (97; 82%) and squamous cell carcinomas (42; 68%). This evidence concerns the gene IDO1 and neoplasm.